Patents by Inventor John David Hooper

John David Hooper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Molecules
    Patent number: 7288398
    Abstract: The present invention related generally to novel molecules and more particularly novel proteinaceous molecules involved in or associated with regulation of cell activities and/or viability. The present invention is particularly directed to novel serine proteinases and a novel kinase and to derivatives, agonists and antagonists thereof. In one embodiment, the present invention provides a novel serine proteinase, referred to herein as “HELA2” or “testisin”, which has roles in spermatogenesis, in suppressing testicular cancer and as a marker for cancers.
    Type: Grant
    Filed: January 7, 2002
    Date of Patent: October 30, 2007
    Assignee: The Council of the Queensland Institute of Medical Research
    Inventors: Toni Marie Antalis, John David Hooper
  • Novel molecules
    Publication number: 20030092154
    Abstract: The present invention related generally to novel molecules and more particularly novel proteinaceous molecules involved in or associated with regulation of cell activities and/or viability. The present invention is particularly directed to novel serine proteinases and a novel kinase and to derivatives, agonists and antagonists thereof. In one embodiment, the present invention provides a novel serine proteinase, referred to herein as “HELA2” or “testisin”, which has roles in spermatogenesis, in suppressing testicular cancer and as a marker for cancers.
    Type: Application
    Filed: January 7, 2002
    Publication date: May 15, 2003
    Inventors: Toni Marie Antalis, John David Hooper
  • DNA molecules encoding human HELA2 or testisin serine proteinases
    Patent number: 6479274
    Abstract: The present invention related generally to novel molecules and more particularly novel proteinaceous molecules involved in or associated with regulation of cell activities and/or viability. The present invention is particularly directed to novel serine proteinases and a novel kinase and to derivatives, agonists and antagonists thereof. In one embodiment, the present invention provides a novel serine proteinase, referred to herein as “HELA2” or “testisin”, which has roles in spermatogenesis, in suppressing testicular cancer and as a marker for cancers.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: November 12, 2002
    Assignee: Amrad Operations Pty., Ltd.
    Inventors: Toni Marie Antalis, John David Hooper